{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:45:29Z","timestamp":1793951129172,"version":"4.8.0"},"reference-count":31,"publisher":"American Association for Cancer Research (AACR)","issue":"18","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cachexia is a life-threatening wasting syndrome lacking effective treatment, which arises in many cancer patients. Although ostensibly induced by multiple tumor-produced cytokines (tumorkines), their functional contribution to initiation and progression of this syndrome has proven difficult to determine. In this study, we used adeno-associated viral vectors to elevate circulating levels of the tumorkines IL6 and\/or activin A in animals in the absence of tumors as a tactic to evaluate hypothesized roles in cachexia development. Mice with elevated levels of IL6 exhibited 8.1% weight loss after 9 weeks, whereas mice with elevated levels of activin A lost 11% of their body weight. Co-elevation of both tumorkines to levels approximating those observed in cancer cachexia models induced a more rapid and profound body weight loss of 15.4%. Analysis of body composition revealed that activin A primarily triggered loss of lean mass, whereas IL6 was a major mediator of fat loss. Histologic and transcriptional analysis of affected organs\/tissues (skeletal muscle, fat, and liver) identified interactions between the activin A and IL6 signaling pathways. For example, IL6 exacerbated the detrimental effects of activin A in skeletal muscle, whereas activin A curbed the IL6-induced acute-phase response in liver. This study presents a useful model to deconstruct cachexia, opening a pathway to determining which tumorkines are best targeted to slow\/reverse this devastating condition in cancer patients. Cancer Res; 76(18); 5372\u201382. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-15-3152","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:09:32Z","timestamp":1466640572000},"page":"5372-5382","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia"],"prefix":"10.1158","volume":"76","author":[{"given":"Justin L.","family":"Chen","sequence":"first","affiliation":[{"name":"1Hudson Institute of Medical Research, Clayton, Australia."},{"name":"2Baker IDI Heart and Diabetes Institute, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Walton","sequence":"additional","affiliation":[{"name":"1Hudson Institute of Medical Research, Clayton, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Qian","sequence":"additional","affiliation":[{"name":"2Baker IDI Heart and Diabetes Institute, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Colgan","sequence":"additional","affiliation":[{"name":"2Baker IDI Heart and Diabetes Institute, Melbourne, Australia."},{"name":"3Department of Physiology, The University of Melbourne, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Hagg","sequence":"additional","affiliation":[{"name":"2Baker IDI Heart and Diabetes Institute, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Watt","sequence":"additional","affiliation":[{"name":"4The Obesity and Metabolism Program of the Biomedicine Discovery Institute, Monash University, Clayton, Australia."},{"name":"5Department of Physiology, Monash University, Clayton, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Harrison","sequence":"additional","affiliation":[{"name":"1Hudson Institute of Medical Research, Clayton, Australia."},{"name":"5Department of Physiology, Monash University, Clayton, Australia."},{"name":"6Department of Molecular and Translational Sciences, Monash University, Clayton, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gregorevic","sequence":"additional","affiliation":[{"name":"2Baker IDI Heart and Diabetes Institute, Melbourne, Australia."},{"name":"3Department of Physiology, The University of Melbourne, Melbourne, Australia."},{"name":"7Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia."},{"name":"8Department of Neurology, The University of Washington School of Medicine, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"2022061706182410500_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tem.2012.10.006","article-title":"Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem","volume":"24","author":"Tsoli","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"2022061706182410500_bib2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1078-0432.CCR-06-2307","article-title":"Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome","volume":"13","author":"Acharyya","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2022061706182410500_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"2022061706182410500_bib4","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PloS ONE"},{"key":"2022061706182410500_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"2022061706182410500_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr Opin Supp Pall Care"},{"key":"2022061706182410500_bib7","doi-asserted-by":"crossref","first-page":"e92966","DOI":"10.1371\/journal.pone.0092966","article-title":"Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation","volume":"9","author":"Tsoli","year":"2014","journal-title":"PloS ONE"},{"key":"2022061706182410500_bib8","first-page":"1091","article-title":"Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival","volume":"21","author":"Moses","year":"2009","journal-title":"Oncol Rep"},{"key":"2022061706182410500_bib9","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI116816","article-title":"Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo","volume":"92","author":"Strassmann","year":"1993","journal-title":"J Clin Invest"},{"key":"2022061706182410500_bib10","first-page":"1353","article-title":"Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft","volume":"1","author":"Tamura","year":"1995","journal-title":"Clin Cancer Res"},{"key":"2022061706182410500_bib11","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1210\/jc.2002-021687","article-title":"Interleukin-6 stimulates lipolysis and fat oxidation in humans","volume":"88","author":"van Hall","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2022061706182410500_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"key":"2022061706182410500_bib13","first-page":"R393","article-title":"Interleukin-6 and cachexia in ApcMin\/+ mice","volume":"294","author":"Baltgalvis","year":"2008","journal-title":"Am J Physiol"},{"key":"2022061706182410500_bib14","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Chen","year":"2014","journal-title":"FASEB J"},{"key":"2022061706182410500_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nature Med"},{"key":"2022061706182410500_bib16","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"key":"2022061706182410500_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/mt.2014.221","article-title":"Development of novel activin-targeted therapeutics","volume":"23","author":"Chen","year":"2015","journal-title":"Mol Therapy"},{"key":"2022061706182410500_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"2022061706182410500_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","article-title":"Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6","volume":"10","author":"Blankinship","year":"2004","journal-title":"Mol Therapy"},{"key":"2022061706182410500_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"2022061706182410500_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/joe.0.1480267","article-title":"Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid","volume":"148","author":"Knight","year":"1996","journal-title":"J Endocrinol"},{"key":"2022061706182410500_bib22","doi-asserted-by":"crossref","first-page":"13805","DOI":"10.1074\/jbc.M110.192625","article-title":"TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4","volume":"286","author":"Winbanks","year":"2011","journal-title":"J Biol Chem"},{"key":"2022061706182410500_bib23","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.91.19.8817","article-title":"Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice","volume":"91","author":"Matzuk","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706182410500_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/hep.1840180219","article-title":"Activin induces cell death in hepatocytes in vivo and in vitro","volume":"18","author":"Schwall","year":"1993","journal-title":"Hepatology"},{"key":"2022061706182410500_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.510250311","article-title":"Regulation of cyclin-dependent kinase inhibitor p21(WAF1\/Cip1\/Sdi1) gene expression in hepatic regeneration","volume":"25","author":"Albrecht","year":"1997","journal-title":"Hepatology"},{"key":"2022061706182410500_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00429-006-0098-9","article-title":"Expression of the neurotrophin receptor TrkB in the mouse liver","volume":"211","author":"Garcia-Suarez","year":"2006","journal-title":"Anat Embryol"},{"key":"2022061706182410500_bib27","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A key role for leukemia inhibitory factor in C26 cancer cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J Biol Chem"},{"key":"2022061706182410500_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/hum.2005.16.178","article-title":"Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates","volume":"16","author":"Lebherz","year":"2005","journal-title":"Hum Gene Therapy"},{"key":"2022061706182410500_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"2022061706182410500_bib30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 prevents cancer-induced cachexia and prolongs survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"2022061706182410500_bib31","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-beta mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nature Med"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/18\/5372\/2742647\/5372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/18\/5372\/2742647\/5372.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T18:29:49Z","timestamp":1748975389000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/76\/18\/5372\/614374\/Differential-Effects-of-IL6-and-Activin-A-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":31,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2016,9,15]]},"published-print":{"date-parts":[[2016,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-15-3152","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22413311.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413287.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413290.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413314.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413284","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508673.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413302.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413308.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413290","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508673","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413299.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413308","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413299","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413287","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413296.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413296","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413284.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413311","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413302","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413314","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}